MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank40
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P40
Within normal range
vs 2Y Ago
-4.2x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025-71.10%
2024-164.38%
202316.81%
2022-21.44%
2021-50561.45%
20200.00%